med. J., 1966, 2, 500-502 sympathetic innervation of the heart, and the cardiac cts of circulating catecholamines, are mediated through drenergic receptors. The increase in heart rate, and the -eased power of contraction normally produced by sympa-:ic stimulation, can be prevented by the recently introduced !ceptor blocking agents, which therefore modify the haemoamic response to exercise. Pronethalol (Alderlin) was the drug of this type without initial sympathomimetic activity, after its introduction for clinical trial it was found to be :inogenic to mice (Paget, 1963) . Propranolol (Inderal) is a ilar compound, which has replaced pronethalol because it ree from carcinogenic activity and more potent weight-forght than pronethalol. loth these drugs have been used in the treatment of angina toris, but the reports on their value have been conflicting. double-blind trials favourable results were obtained with nethalol by Alleyne et al. (1963) and with propranolol by lan (1965) , whereas Srivastava et al. (1964) found proiolol to have little advantage over placebo. Tests involving oducible exercise have also been used to assess the value the drugs in angina. Dornhorst and Robinson (1962) )rted that pronethalol increased effort tolerance in 9 out 14 patients, and Hamer et al. (1964) to 14 years, the average being five years. All were in a stable phase, with no clinical or electrocardiographic evidence of fresh myocardial infarction within the previous three months. None had a history of heart failure, and none was receiving digitalis. Eighteen were normotensive, and two were hypertensive with diastolic pressures persistently over 100 mm. Hg. The resting electrocardiogram (E.C.G.) showed evidence of ischaemic heart disease in 13 patients, the remainder being normal.
The patients were exercised on a motor-driven treadmill with an adjustable speed and slope. The severity of exercise was varied, depending upon the effort tolerance of each patient, and the treadmill was always stopped as soon as pain occurred. The aim was to provoke angina after one and a half to two and a half minutes of walking; if it were caused sooner, the exercise involved would usually be more strenuous than the patients were accustomed to take, and this was thought to be unwise; if the level of exercise permitted a walk of longer duration the circulatory response came close to a " steady state," and only a slight change in the conditions of the experiment could cause a relatively large delay in the onset of pain.
Various precautions were taken to control factors which might influence effort tolerance. First, exercise periods were limited to two a day, about four hours after the previous meal, so that tests were performed with the patients in a semi-fasting state. Secondly, the patients were not permitted to smoke for two hours before they walked, and if glyceryl trinitrate had been taken in the same period the test was postponed. Thirdly, at least 30 minutes of rest preceded each test. Finally, practice walks on the treadmill were repeated, usually six to eight times, until the patients became completely familiar with the techniques and free from apprehension. During the earlier practice tests the degree of effort required to produce pain usually increased, but subsequently the onset of pain provided an accurate and reproducible end-point (Abrahamsen and Kiil, 1966) .
When effort tolerance had become consistent to within a few seconds six tests were carried out, three being performed 90 minutes after oral pronethalol or propranolol, and three 90 minutes after identical placebo tablets. The order in which the tablets were given was varied, and was of course unknown to the patients. Ten patients were investigated with pronethalol (each dose 300 mg.), and 10 with propranolol (each dose 30 to 80 mg. indicating that the drugs acted by causing a reduction in myocardial hypoxia for a given degree of exercise rather than by suppressing anginal pain (see Fig.) .
Discussion
We believe that the practical difficulties of assessing drug therapy in angina pectoris make laboratory tests with reproducible exercise of greater value than even carefully designed double-blind trials. However, laboratory evaluation can also be misleading. The method we have described involves repeated testing over a " training" period; this, together with other precautions to achieve a consistent level of effort tolerance, affords a sensitive method of comparing the effect of a drug with that of placebo. Furthermore, the use of walking as the exercise stress, together with the oral administration of drugs, provides an experimental model closely related to clinical practice.
The technique has confirmed that pronethalol and propranolol can be effective in the treatment of angina pectoris: the majority of patients studied showed an increase in effort tolerance accompanied by delay in the appearance of ischaemic changes in the exercise E.C.G. The beneficial action of these drugs is likely to be due to their blockade of 83-adrenergia activity. A similar effect follows bilateral upper thoracic sympathectomy, and we have shown (Apthorp et al., 1964; Birkett et al., 1965) that there is some correlation between the improvement obtained in a patient after pronethalol or propranolol and the greater improvement which usually follows operation. The mechanism of action is complex: sympathectomy and /-adrenergic blockade cause slowing of the heart-rate and also a reduction in contractility, resulting in increased heart-size, increased filling-pressure, increased duration of systolic ejection, and often some decrease in cardiac output. The overall effect of these actions on coronary flow and myocardial oxygen requirement is not easily predictable at the present time, and may vary from patient to patient. Further studies are in progress to attempt to evaluate the relative importance of some of the factors involved.
The increases in effort tolerance which have been demonstrated were relatively small in most instances. This is due in part to the method of testing: with more gentle exercise, in which patients come near to attaining a " steady state," a similar degree of improvement would have a greater effect in delaying or preventing pain ; the tests made no measure of the benefit resulting from the prevention of sympathetic activity on the heart due to excitement and anxiety; and, finally, the doses of propranolol used in the early part of the study were insufficient to produce full /3-adrenergic blockade, so that greater increases in effort tolerance may have been possible in some patients.
The use of agents of this type is not free from risk. In addition to the important side-effects peculiar to pronethalol, B8-adrenergic blockade can precipitate heart failure, and is contraindicated when myocardial function is severely impaired.
Asthma may be made worse (McNeill, 1964) . The long-term consequences of the metabolic effects on carbohydrate and fattyacid metabolism (Muir et al., 1964) have not yet been assessed.
Nevertheless, /8-adrenergic blockade should be considered in patients not adequately controlled by conventional therapy.
Angina Pectoris-Birkett and Chamberlain
MEDIBAL JORuL Summary
The value of drug treatment in angina pectoris can be accurately assessed by using reproducible treadmill exercise under controlled conditions. A "training" period to allow patients to become completely familiar with the test is of great importance, because during this period effort tolerance usually increases irrespective of drug therapy.
The change in effort tolerance after pronethalol or propranolol, compared with placebo, was measured in 20 patients. A wide variation in response was obtained, but the mean improvement of 36% was highly significant (P<0.001).
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